This page shows the latest Biogen news and features for those working in and with pharma, biotech and healthcare.
It is the first US drug approval for Sanofi’s rare blood disorders franchise, which also includes haemophilia drugs acquired along with Biogen spin-off Bioverativ in 2018.
The two new biosimilars will join products from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit in an assault on AbbVie’s market share for the
Service. It also has seven other pharmaceutical companies on board, including Biogen, AbbVie, Celgene, Genentech, Pfizer, MSD and AstraZeneca.
Meanwhile, the next big hope in the pharma industry’s late stage pipeline for Alzheimer’s is Biogen’s aducanumab. ... Many investors hope to see interim data from Biogen’s phase 3 study of the drug this year, however the company refuses to
The latter including input from Biogen CEO Michel Vounatsos, whose company has two of the few remaining drug candidates which could provide a breakthrough against the disease.
Analysts are now betting that Biogen could be the next company to announce a deal, as it is becoming increasingly reliant on a pipeline focused on Alzheimer’s disease, a
More from news
Approximately 98 fully matching, plus 255 partially matching documents found.
only other SMA treatment available, Biogen’s Spinraza.
However, research from RAND and the University of Southern California that was sponsored by Biogen has found that several European countries lack the capacity to rapidly move a disease-modifying treatment
Samsung Bioepis is a joint venture between Samsung and Biogen Idec; the latter recently (June 2018) invested $700m to bring its stake in the jv to 49.9%.
to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to.
Biogen's spin-out, Bioverativ, had not even got past its first anniversary as a Nasdaq-listed company before being snapped up by Sanofi for $11.6bn (although this is not ... Option, licence. 223. Karyopharm Therapeutics/ Biogen. Oral SINE compound
More from intelligence
Approximately 1 fully matching, plus 35 partially matching documents found.
operations. She joins Sobi from Biogen, where she served as vice president for global supply chain operations and strategic partnerships.
Biogen has appointed Daniel Karp as its executive vice president, corporate development effective 11 June. ... He will also become a member of the executive committee and will report directly to chief executive officer Michel Vounatsos, who said: “We
Nee will lead market research, analytics, forecasting, commercial strategies and competitive intelligence at the company, activities he has practised during his time with Biogen, Amgen and Novartis.
Before joining Patheon, Mullen served as chief executive officer and president at Biogen and before this he held numerous roles at the biotech.
Thomas Bols will focus on reinforcing Acumen’s healthcare practice
More from appointments
Approximately 16 fully matching, plus 32 partially matching documents found.
Major market playerscontributing the global market share of leukemia therapeutics treatment includes Ambit Biosciences Corporation, AriadPharmaceuticals, Inc., Biogen Idec, Inc., Novartis Pharmaceuticals, Bristol-Myers Squibb, Pfizer and others.
Request to View TOC@ . Major market playerscontributing the global market share of leukemia therapeutics treatment includes Ambit Biosciences Corporation, AriadPharmaceuticals, Inc., Biogen Idec, Inc., Novartis Pharmaceuticals, Bristol-Myers Squibb,
Request Report for TOC @ . Major market playerscontributing the global market share of leukemia therapeutics treatment includes Ambit Biosciences Corporation, AriadPharmaceuticals, Inc., Biogen Idec, Inc., Novartis Pharmaceuticals, Bristol-Myers
Biogen. Chugai. Eisai. Helsinn. Ipsen. Johnson &Johnson. Lundbeck. Medtronic. Mentholatum. Novartis.
Alzheimer’s Research UK. Alzheimer’s Society. Basic Needs. Biogen. Butterfly Scheme. Cardiomyopathy UK.
More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.
Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...